BOFAS News & Events

This pages lists all the latest news and upcoming events.

 

To access 'Foot Print' (the BOFAS Bulletin) please click here (members only)

 

Latest News

Website Updates

Research Grants and Email Patient Info Leaflets

The research grants page has been updated and a list of previous grants can now be viewed.

Patient information pages now have a link so that the page link can be shared with patients via email.

12345678

 

BOFAS Hosted Events

BOFAS Principles Course - Dubai

The aim is to give Overseas Trainee Orthopaedic Surgeons a solid grounding in the principles and the decision making in Foot & Ankle Surgery.

There is an emphasis on clinical examination of cases, small group discussions and learning surgical approaches in the cadaver lab.

This is the first course BOFAS is running in UAE and the aim is to expand the Foot and Ankle education and training in the Middle East and Gulf area.

Venue - Le Meridien, Dubai, United Arab Emirates

Documents to download

BOFAS Principles Course Taunton

These courses are aimed at Higher Surgical Trainees / ST3 onwards and are designed to teach the core of Foot and Ankle surgery in an informal and interactive environment. The emphasis is on clinical examination cases, discussion groups and typical day-to-day clinic scenarios. Although not an exam preparation course, content is taught to the standard expected in the FRCS(Tr & Orth) exam; that of a day-one non-specialist orthopaedic consultant. Applications will open on 1st September 2023.

Venue - Taunton (TBC)

 

 

Documents to download


 

BOFAS Affiliated Courses

Other External Events / Courses

Togay Koç
/ Categories: Abstracts, 2025-Jan, Podium

Long term consequences of Total Ankle Replacement versus Ankle Fusion; a 25 year national population study of 41,000 patients

C Hennessy, S Abram, C Loizou, R Brown, B Sharp, A Kendal

Introduction: Definitive treatment for ankle arthritis is either Total Ankle Replacement (TAR) or Ankle Fusion (AF). AF may pre-dispose to hindfoot fusion resulting in a debilitatingly rigid ankle-hindfoot complex. In comparison, TAR may protect against adjacent joint disease but is associated with high revision rates. We do not know the life-time risks of further surgery, adjacent joint disease progression and rare but serious complications of TAR versus AF.

Methods: An England population cohort study was performed using the ONS mortality linked Hospital Episode Statistics database (1998-2023). The primary outcome was Kaplan-Meier curve analysis of revision surgery free survival of TAR versus AF. Secondary outcome measures were the rates of any re-operation to the ankle/hindfoot, including hindfoot fusion rate, 90-day complications, and peri-operative mortality.

Results: 10,335 TAR and 30,704 AF were analysed. The revision rate of TAR was significantly higher than AF at all time points, including 5 years (6.7% vs 2.1%), 10 years (11.1% vs 2.9%) and 20 years (13.1% vs 3.1%). There was no significant difference in 20-year risk of hindfoot fusion following AF (5.94%, 95% CI 5.15 to 6.8%) versus TAR (4.80%, 95% CI 3.4% to 6.6%). TAR was associated with higher risks of intra-operative fracture (0.42% vs 0.10%, RR = 4.35) and re-operation for wound infection (0.26% vs 0.15%, RR 1.74) but fewer pulmonary emboli (0.23% vs 0.58%, RR = 0.40).28.9% of TAR
resulted in a further operation; 60% of which were for exploration/debridement, infection, aspiration and/or revision.

Conclusions: Both TAR and AF are safe definitive treatments of ankle arthritis with low peri-operative risk. The risk of subsequent hindfoot fusion after AF is very low and not significantly higher than after TAR. England TAR revision rates are lower than reported globally with many smaller operations performed before the more complex revision surgery.

Print
212

Documents to download